Citi Maintains a 'Neutral' on Regeneron Pharma (REGN); Doctors Consider Eylea as Replacement for Roche's Lucentis
Go back to Citi Maintains a 'Neutral' on Regeneron Pharma (REGN); Doctors Consider Eylea as Replacement for Roche's LucentisRegeneron (NASDAQ: REGN) | Delayed: 959.92 -4.55 (0.47%) | |||||
---|---|---|---|---|---|---|
Previous Close | $964.47 | 52 Week High | $592.36 | |||
Open | $970.00 | 52 Week Low | $325.35 | |||
Day High | $970.71 | P/E | 251.95 | |||
Day Low | $959.49 | EPS | $3.81 | |||
Volume | 360,153 |
Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) | Delayed: 32.18 -0.46 (1.41%) | |||||
---|---|---|---|---|---|---|
Previous Close | $32.64 | 52 Week High | $35.13 | |||
Open | $32.39 | 52 Week Low | $28.10 | |||
Day High | $32.45 | P/E | N/A | |||
Day Low | $32.15 | EPS | $0.00 | |||
Volume | 1,427,900 |